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Abstract
Several home-produced substances such as krokodil and boltushka are prevalent in many Eastern European
countries. Anecdotal reports of its use have been circulating in Germany and Norway; however, this has not been
confirmed. Its use has also been reported by the media in the USA, although only one confirmed report of its use
exists. Home-produced drugs are associated with high levels of morbidity and a number of complex health issues
such as the spread of blood borne viruses, gangrene, and internal organ damage. The high incidence of HIV rates
amongst people who inject home-produced substances is a public health concern. The resulting physical health
consequences of injecting these crude substances are very severe in comparison to heroin or amphetamine
acquired in black markets. Due to this fact and the increased mortality associated with these substances,
professionals in the area of prevention, treatment, and policy development need to be cognisant of the
presentation, harms, and the dangers associated with home-produced substances globally. This scoping review
aimed to examine existing literature on the subject of home-produced heroin and amphetamine-type stimulant
substitutes. The review discussed the many implications such research may have in the areas of policy and practice.
Data were gathered through the use of qualitative secondary resources such as journal articles, reports, reviews,
case studies, and media reports. The home production of these substances relies on the utilisation of precursor
drugs such as less potent stimulants, tranquillizers, analgesics, and sedatives or natural plant ingredients. The
Internet underpins the facilitation of this practice as recipes, and diverted pharmaceutical sales are available widely
online, and currently, ease of access to the Internet is evident worldwide. This review highlights the necessity of
prevention, education, and also harm reduction related to home-produced drugs and also recommends consistent
monitoring of online drug fora, online drug marketplaces, and unregulated pharmacies.
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Background
The use of drugs in countries of the former socialist re-
public is not a recent phenomenon [1, 2]. Following the
Former Soviet Union’s (fSU) downfall in December
1991, with the addition of massive social and economic
collapse in Eastern Europe, came the escalating problem
of illicit drug use [1–4] especially in Russia, the Ukraine,
the Baltic States, and most other former Soviet republics
[1, 2, 5–10]. Indeed, homemade drug cultures emerged
already in the fSU in the late 1970s and 1980s, as well as
in, Czechoslovakia, Poland, and Hungary [1, 11, 12].
Monetary restrictions and closed borders that preluded
the Soviet Union’s downfall prohibited individuals from
acquiring the substances emerging in the counter cul-
tures of Western Europe and the USA [1, 2]. As a result,
all the countries emerging from the Soviet Union have a
shared history of widespread homemade drug use, pri-
marily opiates and amphetamine-type stimulants (ATS),
through the usage of natural elements, diverted pharma-
ceutical drugs, and even household chemicals [4, 13, 14].
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A foremost concern for public health and drug policy
is the diversion and misuse of pharmaceuticals [15]. The
Internet underpins this concern as both recipes of drug
chemistry and diverted pharmaceuticals are available on-
line and the Internet is now accessible to virtually any-
one worldwide [16]. United Nations Office on Drugs
and Crime (UNODC) reported an increase in the diver-
sion of pharmaceuticals for non-medicinal use in many
countries including Nigeria, the USA, Hong Kong,
Sweden, Australia, Canada, Indonesia, Germany, and
China [16, 17].
There are a substantial number of physical harms result-
ing from injecting homemade drug solutions and count-
less dangers connected to the practice of home cooking of
heroin and ATS substitutes such as the spread of blood
borne viruses (BBVs), skin and soft tissue infections, and
even chemical injuries and burns as a result of explosions
during the cooking process [14, 18–23]. Cooks and con-
sumers alike are exposed to these chemicals, as are poten-
tially their families and the environment [24, 25]. Further
research in this area will be of great benefit to healthcare
workers, treatment providers, and policy makers. As the
consequences of injecting these homemade substances are
considerably more acute than existing illicit narcotics [26],
and life expectancy lower [19], treatment providers glo-
bally should be cognisant of the dangers of, presentation,
and harms related to homemade drug use. Policy makers
should be responsive, as homemade drug use in
countries outside of Eastern Europe may be probable
for reasons such as the current global economic cli-
mate and the effects of resulting austerity measures
on vulnerable communities such as heroin users in
Greece turning to cheap homemade methampheta-
mine; mephedrone and MDPV taking over people
who inject drugs (PWID) scenes in Romania; and
effortless access to unregulated pharmacies and online
drug markets [16]. By scoping the literature, health-
care workers and treatment providers will benefit, and
highlighted gaps in current research should inform
practice and policymakers. An incidence of this type
of drug production may be detrimental to PWID and
become a major public health concern. This scoping
study will focus on the history of homemade drug
use worldwide but particularly in Eastern Europe, as
it is more prevalent there. The harms associated with
the practice of producing and consuming homemade
drugs will be highlighted for harm reduction purposes
and aimed toward prevention, treatment, and policy.
The scoping review
Scoping studies are gradually being encouraged for the
extensive searching of literature on specific subjects.
They are primarily used to emphasise the gaps and key
issues in the current evidence base and to find areas that
require further research, practical, and policy interven-
tions [15, 27–29]. It is important to acknowledge the
limitations of a scoping study. As the quantity of data
generated in a scoping study is sometimes considerable,
the decision to include all material available versus a
more detailed analysis of a smaller number of studies
can be difficult. Scoping studies do not appraise the evi-
dence quality in the primary research papers, and as a
result, scoping studies simply offer a descriptive or nar-
rative interpretation of available research [16, 27]. This
scoping review employed qualitative secondary sources
together with peer reviewed journal articles, reports, re-
views, case studies, and some media accounts. A thor-
ough list using many different search terms was used to
perform a literature search. These terms included
“homemade drugs”, “kitchen chemistry”, “krokodil”, “des-
omorphine”, “boltushka”, “drug formulation tampering”,
and “online drug markets”. To guarantee all articles rele-
vant to the study were included, a broad search was con-
ducted using many databases: EBSCO Host, Science
Direct, PubMed, PsycINFO, and MEDLINE. A set of cri-
teria for inclusion and exclusion in the study were put in
place. Inclusion criteria consisted of home-produced
substances limited to ATS and heroin substitutes and
full-text access. Exclusion criteria consisted of incompre-
hensible language, animal studies, and insignificance to
the scoping review (see Fig. 1 and Table 1).
Heroin and amphetamine-type stimulants
Heroin addiction is defined as a chronic relapsing condi-
tion that, for many, is an unrelenting, lifelong illness
with severe effects. This is particularly relative to short
life expectancies and high rates of morbidity [30–33].
Ninety percent of the world’s heroin supply is directly
from opium grown in Afghanistan. Heroin that is
produced from Afghan poppies is shipped worldwide
[34]. With an estimated 3.1 million consumers, Europe
is the main destination for Afghan heroin. In Europe,
the Russian Federation is by far the largest consumer of
Afghan heroin [34] with 2.3 % of its population injecting
opioid drugs, indicative of Russia’s proximity to
Afghanistan [23]. Approximately 1.5 million people con-
sume heroin in the Russian Federation and 1.6 million
dispersed over other European countries [34].
The most widespread used opiate worldwide is Codeine,
an alkaloid prepared from opium via a process known as
methylation [35–37]. Codeine is employed in several dif-
ferent ways such as a sedative, analgesics, treatment of tu-
berculosis, and anti-diarrhoeal [36, 38]. In recent years,
codeine-containing cough syrups (CCS) have been seen as
independent substances of abuse and moreover as substi-
tution for conventional drugs of abuse, e.g. amphetamines,
cocaine, and opiates [37, 39, 40]. Combination analgesics
containing codeine (CACCs) are a mixture of codeine and
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other substances, e.g. ibuprofen, paracetamol, or aspirin.
CACCs are obtainable over-the-counter (OTC) drugs in
some countries worldwide such as Ireland (Solpadeine®),
Australia (Panadeine®), and the Ukraine (Codelac® and
Terpincod®). These sales of CACCs were banned in Russia
in June 2012 [22]; however, codeine has simply moved to
the black market and is therefore still available. CACCs
bought over the counter are considered “safe” to treat pain,
if used in accordance with the recommended dosages. Yet,
persistent long-term use and unnecessary dosing patterns
can result in dependence physically and psychologically;
continual headaches as a result of overuse of the medica-
tion; and a myriad of other complex medical issues [41, 42].
Amphetamine-type stimulants (ATS) include amphet-
amine, d-amphetamine, methamphetamine, methylphen-
idate, 3,4-methylenedioxymethamphetamine (MDMA)
and also cathinone, methcathinone, pseudoephedrine,
fenetylline, and ephedrine [43–45]. These are a sizeable
collection of psychoactive compounds that all contain
natural elements in their chemical structure [45]. ATS
operate on a person’s nervous system and have powerful
effects on the individual’s mind and body. Some of these
include appetite suppression, heart rate elevation, in-
tense happiness, and mental and energy awareness. Al-
though ATS are characteristically controlled substances,
a number of them are regulated and utilised for treating
disorders such as attention deficit hyperactivity disorder
(ADHD), narcolepsy, and depression that is resistant to
treatment [46]. There currently stands a general non-
medicinal use of such stimulants [45, 47] with ATS pro-
duction and manufacture occurring in numerous parts
of the world [48]. Indeed, ATS use is more prevalent
than cocaine or opiates [49]. It is suggested that there
are 35 million people using ATS worldwide, compared
with 29 million people consuming opiate and/or cocaine
[34, 48, 50]. There are several variations in the form of
ATS produced globally, e.g. in Europe, ATS manufacture
is primarily in tablet or powder forms of ecstasy
(MDMA) and amphetamine. In the Czech Republic and
other countries of Central and Eastern Europe, home-
made methamphetamine is locally known as “Pervitin”,
“Vint”, or “Shirka” [1, 2, 51].
History of homemade drug use
Throughout the 1970s, information on Western youth
and counter culture increasingly triggered the interest
in psychoactive drugs amongst young adolescents.
The practice of home-cooked drugs most likely com-
menced 10 to 15 years before the political changes,
on the fringes of dissident intellectual “third culture”
or “underground” circles. The growing aversion of the
stifling Soviet ideology made these young people
equally distrustful and disdainful of the harsh Soviet
anti-drug propaganda—often phrased in the anti-
Western Agit-Prop discourse and images they were
subjected to. Keen on emulating the experiences of
their western peers, Soviet Youth took their parents’
tradition of Samogon to the next level [1, 2] and used
precursor drugs from natural plant ingredients or
over-the-counter or prescription drugs with psycho-
active properties—containing less potent stimulants,
tranquillizers, analgesics, and sedatives—to produce
their own drugs [1, 10, 14, 19, 20, 52].
In Poland, students from the University of Gdansk
(the birthplace of the Solidarity movement) reportedly
Fig. 1 Flow diagram charting inclusion and exclusion criteria for
this study
Table 1 Categories used to organise the literature
Homemade drug use in Eastern Europe
Homemade drug use outside of Eastern Europe
Heroin and amphetamine-type stimulants/substitutes
Harms associated with homemade drugs
Drug and formulation tampering
The Internet
Scoping studies
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first synthesised “kompot,” homemade heroin, by extract-
ing the opioids from poppy straw and acetylation of the
morphine content [11, 53]. In early 1980s Prague,
“Freud” had taken a few chemistry courses at a technical
university before he first synthesised the (in)famous
“pervitin” or “piko” (methamphetamine) from ephedrine,
the active ingredient in over-the-counter cold medica-
tions [54]. Both drugs rapidly diffused amongst young
people in both countries in the 1990s. Kompot was the
driving force behind the 1980s HIV epidemic amongst
PWID in Poland [5]. Although the Czech Republic has
been spared widespread HIV infection amongst PWID,
pervitin remains the problem child on the Czech drug
scene [1, 54, 55].
During the 1980s these recipes diffused across most
Soviet countries, but much less in its Central
European vassal states. With that came adjustments
of formulae and chemicals used in the synthesis [44],
leading to a simpler, cruder process and a range of
monikers. Heroin made from poppies became known
under the moniker of “cheornaya” (black, referring to
the colour of the final liquid drug) and “hanka” in
Russia and “shirka” in Ukraine.
Homemade methamphetamine became “vint”1 in
Russian and methcathinone “jeff”, or “mulka”, while in
Ukrainian, these drugs were termed “belyi”2 and “ephe-
drone”, while cathinone is termed “Bolthuska”3 [1, 44].
This argot is often very local and remarkably elastic. In
some Russian towns, methamphetamine was called
belyi/beloye and vint in many places in Ukraine. The
word belyi is also used for ephedrine or methcathinone
or may refer to any stimulants (white for stimulants;
black for opiates).
Both the home-produced opioids and ATS are pro-
duced using caustic chemicals, such as sulphuric acid
(H2SO4), phosphorus, iodine, and industrial or house-
hold solvents by (often unskilled) cooks under the most
primitive laboratory conditions—in kitchens and base-
ments. It should not come as a surprise that much of
these corrosive reactants remain present in the final
drug [44]. The grave and harsh reality of this practice is
that the substances finally produced come primarily in
liquid form, ready for injection, which is the usual mode
of use in the region [7].
The phenomenon of homemade drug use continues to
influence Eastern European drug culture (see Fig. 2)
[53]. Early 2011 saw a remarkable escalation in the num-
ber of reports in the media of the use of a new home-
made drug known as “krokodil” (Russian: крокодил),
also “Russian Magic”, “crocodile”, or by its chemical
name “Desomorphine” [19, 20]. Research has shown that
this home-produced opiate first appeared in Russia
around 2002/2003 [19, 20, 23], although Czech drug
cooks also modestly produced a drug from codeine
based analgesics in the 1980s, known as “braun” or
“brown” due to its colour [1, 2] (see Table 2) [16].
Desomorphine’s sedative properties are ten times
stronger than the effects of heroin. However, it has a
shorter half-life; therefore, dependence may rapidly
appear with continued administration [19, 20]. There are
both serious short- and long-term negative health conse-
quences and high mortality rates associated with kroko-
dil, primarily resulting from the crude desomorphine
extraction and the failure to separate or filter out its
numerous toxic by-products [19, 20, 56–58]. Evidence of
widespread use of an injectable home-produced cathinone
Fig. 2 Summary map
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Table 2 Homemade drug solutions, street names, ingredients, geographic area of use and key public health concerns
Street name Drug type/chemical Ingredients Key adverse health and social consequences Country/city of use
Krokodil.
Other common
street names:
Russian Magic,
Crocodile,
Russian Heroin
Opiate-
desomorphine
Codeine, gasoline or
paint thinner, iodine,
red phosphorous,
tropicamide
Injecting risks for BBV transmission and risks present
in the production process, contamination, chemical
reaction, sharing of paraphernalia, and group injecting
practices.
High mortality rates.
Krokodil users presenting in surgeries/emergency rooms
with serious and advanced medical complications.
Undesirable medical and social costs.
Russia, Ukraine, Georgia,
Kazakhstan. Germany
(Bochum, Berlin, Frankfurt),
Norway (Tromsø).
Also:
Anecdotal reports in UK,
Czech Republic, France,
Belgium
Boltushka.
Other common
street names:
Baltushka, Balka
Cathinone Ephedrine,
pseudoephedrine,
warm water,
household vinegar,
and potassium
permanganate
Injecting risks for BBV transmission and risks present
in the production process, contamination, chemical
reaction, sharing of paraphernalia, and group injecting
practices.
Long-term users of boltushka can experience partial
loss of cognitive function, Alzheimer-type symptoms,
and possible brain damage.
Manganese-induced Parkinsonism, which is irreversible.
Undesirable medical and social costs.
Odessa*
Jeff
Other common
street names:
Jaff, Cat, Mulka,
Ephedrone
Methcathinone Phenylpropanolamine,
warm water,
household vinegar,
and potassium
permanganate
Injecting risks for BBV transmission and risks present
in the production process, contamination, chemical
reaction, sharing of paraphernalia, and group injecting
practices.
Manganese-induced Parkinsonism.
Injecting risks for BBV transmission.
Undesirable medical and social costs.
Ukraine
Fentanyl patches
(new and used).
Other common
street names:
China White,
White Persian
Opiate Fentanyl,
acetaminophen,
caffeine
Fentanyl use is associated with increased odds of
overdose.
Criminality such as misusers who resort to obtaining
used patches from elderly nursing home residents,
and searching hospital and nursing home dumpsters
for discarded patches.
Undesirable medical and social costs.
Russia, Belarus
Cheornaya Opiate Poppy Straw,
cigarette ash,
sodium bicarbonate
Access to poppy straw is seasonal and when it is
scarce, injectors will turn to other opiate-type drugs.
Injecting risks for BBV transmission and risks present
in the production process, contamination, chemical
reaction, sharing of paraphernalia, and group injecting
practices.
Circulatory damage and soft tissue infections amongst
injectors.
Undesirable medical and social costs.
Russia
Himiya Opiate Poppy straw Access to poppy straw is seasonal and when it is
scarce, injectors will turn to other opiate-type drugs,
including krokodil.
Injecting risks for BBV transmission and risks
present in group injecting practices.
Undesirable medical and social costs.
Ukraine
Braun
Other common
street name:
Brown
Opiate Mixture of morphine
and codeine products,
e.g. hydrocodone
Injecting risks for BBV transmission and risks present
in the production process, contamination, sharing
of paraphernalia, and group injecting practices.
Czech Republic
Kompot
Other common
street names:
Polish heroin
Opiate Poppy straw,
acetic anhydride,
acetone
Access to poppy straw is seasonal and when it is
scarce, injectors will turn to other opiate-type drugs.
Injecting risks for BBV transmission
Guillain-Barré Syndrome.
Injecting risks for BBV transmission and risks
present in group injecting practices.
Undesirable medical and social costs.
Poland
Shirka (Ukraine)
Other common
street names:
Cherniashka,
Black, Hanka
Opiate Poppy straw Access to poppy straw is seasonal and when it is
scarce, injectors will turn to other opiate-type drugs
Injecting risks for BBV transmission and risks present
in group injecting practices.
Undesirable medical and social costs.
Ukraine, Moldova
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known as “boltushka” was noted by Chintalova-Dallas et
al. [44]. This ATS was initially reported in Odessa,
Ukraine in 2005. Boltushka is produced by mixing vinegar,
warm water, potassium permanganate (KMnO4) together
with the precursor, phenylpropanolamine (PPA) from
crushed “koldack” or “teffedrin” tablets [44, 59–61]. The
tradition of home-produced drugs has been reported in
several other countries such as Norway [14, 62, 63],
Georgia, Ukraine, Kazakhstan [14, 23, 64], New Zealand
[65], and Germany [14, 63, 66] where the use of krokodil
is reported [16]. Greece reported a homemade version
of methamphetamine called “shisa” or “drug of the
poor” [67, 68], while in the Netherlands and other
European Countries, the use of homemade gamma-
hydroxybutyric acid (GHB) is a small but intensive
problem [69, 70]. Reports indicate that the occurrence
of homemade drug use has transpired as a result of
reduced heroin availability in Russia, the Baltic States,
and the five central Asian countries [16, 22, 55, 71–73].
Drug and formulation tampering and the Internet
Using illicit drugs has now been exceeded by the non-
medicinal use and abuse of diverted pharmaceuticals in
the USA [13, 74]. (Pseudo) Ephedrine, codeine, codeine
cough syrups (CCS), and fentanyl patches are the most
ordinarily tampered with pharmaceuticals. Lankenau et
al. [75] suggest that formulation tampering with these
drugs allows for dispensing higher doses and therefore is
cost effective. Motivations for tampering with pharma-
ceuticals involve numerous reasons including increasing
the bio-availability of the drug, quicker onset of the
effects, and to boost the drugs psychoactive effects [16].
Sedatives, stimulants, analgesics, and tranquillizers are
broadly pursued, measured, and tampered with for the
purpose of recreational intoxication [13, 76]. The Inter-
net is accessible to many people worldwide and is a
prime source of information for recreational drug con-
sumers, interested in tampering with formulations due
to the wealth of information on websites, including drug
user fora, providing potential home cooks with advice
and tips on the techniques and recipes. This is a concern
for public health, given the pervasive nature of the Inter-
net worldwide [13, 16]. Previous successes as well as
failures are documented and discussed (see www.erowid.
org; www.bluelight.ru; www.drugs-forum.com) [13, 77].
Advice includes description of methods for tampering
such as crushing, separating, purifying, and optimum
usage [13, 78–83]. Moreover, online market places found
on the “deep web” or “darknet” are now accessible. The
deep web is described as the section of the Internet that
is not searchable with established search engines, e.g.
google. The darknet is described as a small area within
the deep web and has been purposefully concealed and
cannot be accessed via usual web browsers [84]. The
most well-known online market is the Silk Road Market-
place which was active between Feb 2011 and October
2013, and was followed by Silk Road 2.0 active from
November 2013 to November 2014 [85]. Although Silk
Road and Silk Road 2.0 have been shut down, other
online marketplaces can be found on the “deep web”
where the site owners, buyers, and vendors can stay
somewhat anonymous due to their IP addresses being
Table 2 Homemade drug solutions, street names, ingredients, geographic area of use and key public health concerns (Continued)
Shirka (Odessa*) Methamphetamine Ephedrin,
Pseudoephedrine
Binge-using patterns that enhance the probability
of unintentional overdoses.
Injecting risks for BBV transmission, i.e. risks present
in the production process, contamination, sharing
of paraphernalia, and group injecting practices.
Undesirable medical and social costs.
Odessa*
Hemia Opiate Poppy straw Access to poppy straw is seasonal and when it is
scarce, injectors will turn to other opiate-type drugs,
including krokodil and kolyosa.
Injecting risks for BBV transmission and risks present
in group injecting practices.
Undesirable medical and social costs.
Odessa*
Kolyosa Opiate Mixture of codeine-
containing pills
Users will turn to this due to poppy straw being
unavailable with associated overdose and injecting risks.
Injecting risks for BBV transmission and risks present
in the production process, contamination, sharing
of paraphernalia, and group injecting practices.
Undesirable medical and social costs.
Moldova
Pervitin
Other common
street name:
Vint, Piko
Methamphetamine Ephedrine,
pseudoephedrine,
industrial chemicals
such as gasoline,
toluene and
tetrachlorethylene
Binge-using patterns that enhance the probability of
unintentional overdoses.
Injecting risks for BBV transmission and risks present
in the production process, contamination, sharing of
paraphernalia, and group injecting practices.
Undesirable medical and social costs.
Czech Republic, Moldova
* Ukraine - refers to all cities in Ukraine, except Odessa, which has a range of different terms/names for their homemade drugs
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masked and random routing via peer-based computer
networks, using the TOR browser [85–87]. These online
marketplaces are innovative new avenues for drug sales
[88, 89, 90, 91], facilitating anonymous acquisition and
supply of licit drugs, pharmaceuticals, and illicit drugs
alike [91]. Additionally, the Internet hosts a number of
drug discussion fora, wherein users publicly and an-
onymously exchange knowledge. Several Darknet drug
markets have discussion fora as well, where, for example,
the quality of the drugs and vendors are rated and dis-
cussed. These drug fora offer users practical tools prior to
purchase and use of substances and indigenous harm re-
duction. Numerous studies have emphasised the import-
ance of harm reduction occurring amongst these online
communities [92–96]. Between 2010 and 2012, Russian
policy makers highlighted the negative effect the Internet
had in the dissemination of information related to krokodil
production and use. A marked rise in online searches for
krokodil preparation and methods to purchase was noted
[16]. However, a major reduction in Internet searches for
krokodil related information was noted after the ban on
pharmaceutical sales of codeine, June 1, 2012 [22].
Harms associated with homemade drug use: implications
for harm reduction
The well-established tradition of “kitchen chemistry” [16]
is still dominating stimulant and opioid use in many
parts of Eastern and Central Europe [23]. These home-
made drugs are rife in marginalised strata of society such
as amongst people with lower socioeconomic status or
homeless individuals, due to their low costs and wide-
spread availability of OTC or diverted pharmaceuticals
and easy access to recipes [16, 23, 97]. In Russia, the
process for producing krokodil only comprises of a small
amount of precursor pharmaceuticals, e.g. one to five
packets of codeine based analgesics or 80 to 400 mg of co-
deine and takes approximately 45 min to cook, sometimes
less. Although other home-produced substances are not
without harms, krokodil seems to be associated with particu-
larly severe complications and ghastly health outcomes [10].
The severe morbidity associated with injecting krokodil is
likely a function of the short half-life of the drug, dictating
frequent injection, missing or inapt reactants, and incom-
plete synthesis, leaving large fractions of reactants and result-
ing in an extremely corrosive drug cocktail [14, 65].
The transmission of BBVs is a major health concern
associated with any form of injecting drug use [16, 22].
The primary causes of BBV transmission are the collect-
ive use of injecting equipment (needle sharing) and
sharing of liquefied drugs [98–101]. These behaviours
are also important drivers of skin and soft tissue infec-
tions (SSTIs) around injection sites, affecting 10–30 % of
PWID [102–104] and associated with loss of venous
access and intramuscular or subcutaneous injection
[102, 104, 105]. It has been documented that there is a
high risk of BBV transmission amongst PWID, through
the sharing not only of needles but also of other equip-
ment used in the process. HIV and hepatitis C infection
rates amongst PWID are extremely high in Russia,
Ukraine, Georgia, and other fSU countries [106]. These
first two countries are reported as the most affected by
krokodil use [23].
Grund et al. [14] summarised the major concerns
related to krokodil use, as reported in the literature
and by PWID, such as skin irritations, ulcers, scale-
like skin deformations that eventually turn green (like
a crocodile skin) and black (necrotic), jaw osteonecro-
sis, thrombophlebitis, muscle damage, thyroid injury,
inflammation of kidneys and the liver, endocrine com-
plications, amputation of limbs and, ultimately, death
[16, 18–20, 56, 107, 108]. Reportedly, limb amputa-
tions or jaw removals are often the only lifesaving
intervention [20, 57, 108]. Reportedly, people who
inject krokodil often present at medical services in
the later stages of disease because they fear medical
stigma and close ties between medical providers and
law enforcement or other systems of social control,
such as child protection agencies [14, 109–111].
Krokodil is not the only homemade substance to have
severe physical complications. In recent years, several
Eastern European countries have reported “Manganese
Induced Parkinsonism” associated with injection of “bol-
tushka” (homemade cathinone). First described as “Man-
ganism”, as early as 1837 [112], overexposure to
manganese is a severe condition that can become mani-
fest after only a few months of boltushka injecting, with
symptoms of dysarthria, hypokinesia, dystonia, and dam-
aged posture [113–115]. Boltushka synthesis includes
the oxidation of (the precursor) with permanganate or
“marganzovka”, a commonly used disinfectant in Russia,
in water [44]. During the reaction, Manganese (Mn) is
released and toxic levels of remnants remain in the
liquid drug. The rapid progression of Manganism
amongst boltushka consumers [115, 116] points at
short term, continuous exposure to perhaps extremely
high concentrations of manganese. Although data are
missing, we suggests that manganese concentrations
in people who inject homemade (meth)cathinone may
exceed levels amongst people affected by industrial
pollution and perhaps even those of workers in the
battery manufacturing and manganese processing
industries, who, reportedly, are most at risk [117].
This is a serious concern for PWID, treatment
providers, healthcare workers, and policy makers alike
as the resulting Parkinsonism syndrome is not revers-
ible [44]. Studies suggest Manganism related to
(meth)cathinone injection amongst immigrants in
Western Europe and in Canada [116]. Individuals
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have reported experiencing manganese toxicity from
using MCAT (4-methylmethcathinone) [118] in online
drug community forums [119].
Countries outside of Eastern Europe should be well-
informed about these grave public health concerns. A
variety of opioid and stimulant syntheses are described
in detail on the Internet, and the precursors and reac-
tants are readily available. This may lead to such harmful
substances emerging in unexpected settings. Indeed,
traditional drug diffusion theory [120, 121] accounts
poorly for the way in which new drug trends spread geo-
graphically, from one locality to another, and culturally,
between different social groups or communities, and
also how information about their risks is being shared.
Emerging drug trends no longer necessarily com-
mence in (cultural) capitals, harbour cities or along
(physical) drug trading routes. Indeed, in the gloca-
lised and Vernetzte twenty first century, iDrugs and
new drug trends may emerge in any municipality,
large or small, urban, or rural. Digitalisation of drug
markets, immigration, and global travel may also be
of significant influence [16].
Due to the adverse health issues associated with these
homemade substances, governmental reaction is neces-
sary so as to increase the regulation of over the counter
and prescribed medications, and also to provide coordi-
nated services such as counselling services, medical
supports, wound and infection management, testing and
support for HIV, outreach, and rehabilitation services for
users of the substances [16, 20, 58, 65, 122–126]. Devel-
opment of harm reduction tactics such as hygiene edu-
cation, needle exchanges, bleach distribution, provision
of filters, foil packs to try encourage users to reverse
route of administration, provision of safer recipes for
home-produced substances, treatment such as opiate
substitution and antiretroviral therapy, and prevention
programmes are vital [16, 44, 123–126]. Continuing
research that will explore users’ awareness of harms of
homemade drugs, user practices, users’ experiences of
services, and trajectories of use are fundamental to
informing harm reduction approaches [14, 16]. Contin-
ued surveillance and monitoring at harm reduction
programmes using internal data systems to monitor new
trends is warranted.
Conclusion
Home-produced substances that replace illicit ones, such
as heroin and amphetamines, are associated with many
complex health issues and high levels of morbidity. This
scoping review has presented extant literature on the
topic and highlights how this issue is a growing and
concerning public health imperative warranting drug
user and online surveillance, targeted harm reduction
and clinical responses.
Endnotes
1“Screw,” with reference to some of its less pleasurable
side-effects.
2“White”.
3“Chatterbox”.
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